These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38522775)

  • 1. Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.
    Zhang D; Xie J; Sun F; Xu R; Liu W; Xu J; Huang X; Zhang G
    Cancer Lett; 2024 May; 589():216819. PubMed ID: 38522775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHLA2 immune-regulatory roles in cancer.
    Mortezaee K
    Biomed Pharmacother; 2023 Jun; 162():114639. PubMed ID: 37011487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy.
    Ying H; Xu J; Zhang X; Liang T; Bai X
    EBioMedicine; 2022 May; 79():103987. PubMed ID: 35439678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy.
    Li Y; Lv C; Yu Y; Wu B; Zhang Y; Lang Q; Liang Z; Zhong C; Shi Y; Han S; Xu F; Tian Y
    J Adv Res; 2023 May; 47():137-150. PubMed ID: 35933091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
    Wei Y; Ren X; Galbo PM; Moerdler S; Wang H; Sica RA; Etemad-Gilbertson B; Shi L; Zhu L; Tang X; Lin Q; Peng M; Guan F; Zheng D; Chinai JM; Zang X
    Sci Immunol; 2021 Jul; 6(61):. PubMed ID: 34244312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of HHLA2 in Solid Tumors-A Review of the Literature.
    Kula A; Koszewska D; Kot A; Dawidowicz M; Mielcarska S; Waniczek D; Świętochowska E
    Cells; 2024 May; 13(10):. PubMed ID: 38786018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1.
    Bhatt RS; Berjis A; Konge JC; Mahoney KM; Klee AN; Freeman SS; Chen CH; Jegede OA; Catalano PJ; Pignon JC; Sticco-Ivins M; Zhu B; Hua P; Soden J; Zhu J; McDermott DF; Arulanandam AR; Signoretti S; Freeman GJ
    Cancer Immunol Res; 2021 Feb; 9(2):156-169. PubMed ID: 33229411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHLA2: An Emerging Immune Checkpoint for Cancer Immunotherapy.
    Cao Z; Wang Y; Cheng SC; He N
    J Leukoc Biol; 2024 Jul; ():. PubMed ID: 38973642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma.
    Xiao Y; Li H; Yang LL; Mao L; Wu CC; Zhang WF; Sun ZJ
    Dis Markers; 2019; 2019():5421985. PubMed ID: 31089395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H7: A potential target for cancer immunotherapy.
    Su Q; Du J; Xiong X; Xie X; Wang L
    Int Immunopharmacol; 2023 Aug; 121():110403. PubMed ID: 37290327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer.
    Wang D; Wu S; He J; Sun L; Zhu H; Zhang Y; Liu S; Duan X; Wang Y; Xu T
    J Exp Clin Cancer Res; 2023 Sep; 42(1):222. PubMed ID: 37658376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Endogenous Retrovirus-H Long Terminal Repeat- Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival.
    Farrag MS; Ibrahim EM; El-Hadidy TA; Akl MF; Elsergany AR; Abdelwahab HW
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1883-1889. PubMed ID: 34181347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HHLA2 predicts improved prognosis of anti-PD-1/PD-L1 immunotherapy in patients with melanoma.
    Huang FX; Wu JW; Cheng XQ; Wang JH; Wen XZ; Li JJ; Zhang Q; Jiang H; Ding QY; Zhu XF; Zhang XS; Ding Y; Li DD
    Front Immunol; 2022; 13():902167. PubMed ID: 36003385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.
    Cheng H; Borczuk A; Janakiram M; Ren X; Lin J; Assal A; Halmos B; Perez-Soler R; Zang X
    Clin Cancer Res; 2018 Apr; 24(8):1954-1964. PubMed ID: 29374053
    [No Abstract]   [Full Text] [Related]  

  • 15. Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer.
    Kula A; Dawidowicz M; Mielcarska S; Kiczmer P; Skiba H; Krygier M; Chrabańska M; Piecuch J; Szrot M; Robotycka J; Ochman B; Strzałkowska B; Czuba Z; Świętochowska E; Waniczek D
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, Clinical Significance, and Receptor Identification of the Newest B7 Family Member HHLA2 Protein.
    Janakiram M; Chinai JM; Fineberg S; Fiser A; Montagna C; Medavarapu R; Castano E; Jeon H; Ohaegbulam KC; Zhao R; Zhao A; Almo SC; Sparano JA; Zang X
    Clin Cancer Res; 2015 May; 21(10):2359-66. PubMed ID: 25549724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Zhou QH; Li KW; Chen X; He HX; Peng SM; Peng SR; Wang Q; Li ZA; Tao YR; Cai WL; Liu RY; Huang H
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer.
    Zhang X; Qin Y; Chen X; Xiong M; Shu S
    Technol Cancer Res Treat; 2024; 23():15330338241240683. PubMed ID: 38613340
    [No Abstract]   [Full Text] [Related]  

  • 19. HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma.
    Xu Y; Huang Z; Yu X; Li Z; Zheng L; Xu J
    Biologics; 2021; 15():329-341. PubMed ID: 34413629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HHLA2, a New Immune Checkpoint Member of the B7 Family, Is Widely Expressed in Human Lung Cancer and Associated with EGFR Mutational Status.
    Cheng H; Janakiram M; Borczuk A; Lin J; Qiu W; Liu H; Chinai JM; Halmos B; Perez-Soler R; Zang X
    Clin Cancer Res; 2017 Feb; 23(3):825-832. PubMed ID: 27553831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.